Media

  • Home
  • Media

Featured in Dagens Industri, Sweden’s leading business newspaper

Dagens Industri, 2025
READ THE ARTICLE

Svenska forskare utvecklar nytt läkemedel mot fetma

Life Science Sweden, 2023

READ THE ARTICLE

Empros växlar upp - gör sig redo för fas 3-studier.

Svenska Dagbladet: Innovation & Forskning, 2023

READ THE ARTICLE

Empros Pharma i framkant med sin behandling mot obesitas

Svenska Dagbladet: Future of Swedish Healthcare, 2023
READ THE ARTICLE

Empros Pharma was founded in 2013 by researchers and entrepreneurs at Uppsala University together with the investor Flerie Invest. The company is developing EMP16, a pharmaceutical weight management treatment, planned to be ready for launch in 2027. 

Pages

Contact

Linkedin
© 2025 empros pharma

Hemsidan är byggd av Weblab